Journey in China

#MiraclesOfLife #ChinaCART #CancerTreatment #CancerWarrior #TumorTherapy #patientstory #lymphoma

CAR-T cell therapy is a groundbreaking cancer treatment that harnesses the patient’s own immune system by engineering T cells to recognize and attack cancer cells. In recent years, this therapy has brought new hope to patients with refractory hematologic cancers worldwide. China, with its advanced medical technology and extensive clinical experience, has become one of the leading countries globally for CAR-T therapy.

#### **Patient Story**

Ana is a vibrant dance coach from Russia. She loves life, en

joys a happy marriage, has two adorable cats, and her students, whom she affectionately calls her “kids.” However, fate cruelly altered her life when she was diagnosed with B-cell lymphoblastic lymphoma (B-LBL).

During her long battle after the diagnosis, Ana underwent chemotherapy, localized radiation therapy, and even traveled to Europe for an allogeneic hematopoietic stem cell transplant. Despite her resilience, the shadow of relapse followed her closely, as conventional chemotherapy and other treatments failed to yield lasting results, and the cancer returned.

#### **CAR-T Therapy for B-LBL in China**

When hope seemed to fade, Ana decided to try a cutting-edge treatment—CAR-T cell therapy. This innovative therapy has shown remarkable efficacy in treating relapsed and refractory hematologic cancers worldwide. With a strong will to live, Ana sought consultation with experts from the Advanced Medicine in China team and was transferred to a hospital in China, hoping for a new chance at life. In China, after comprehensive examinations, the medical team found that the tumor had spread to her limb bones and bone marrow, proliferating at an alarming rate. Faced with such a high tumor burden, the team decided to administer CD19-targeted CAR-T cell therapy and took steps to reduce the tumor load beforehand to improve the chances of success.

A miracle occurred within just two weeks of treatment. On the 14th day, a bone marrow biopsy revealed that Ana’s tumor cells had disappeared, and the treatment had shown significant results. Even more encouraging was the fact that her pain symptoms had completely vanished, and her overall condition gradually improved. While full recovery will take time to observe, Ana’s condition has stabilized as expected.

#### **Remission and Future**

Now, Ana is in the recovery phase, and her treatment in China has made tremendous progress. Future monitoring and care will continue remotely with the Chinese medical team. This treatment journey not only reignited hope in Ana’s life but also serves as an inspiration to many others battling the disease: CAR-T cell therapy might be a beacon of light in the fight against hematologic cancers.

Ana’s story is a vivid example of CAR-T therapy in China, highlighting the country’s leading role in the global fight against cancer. We hope this innovative therapy can offer new chances of life to many more patients like Ana.

To assess whether the condition is suitable for CAR-T therapy, you can submit pathology reports, treatment history, and discharge summaries to the Medical Department of <Advanced Medicine in China> for preliminary evaluation!

WhatsApp: Https://wa.me/+8613717959070

Email: doctor.huang@globecancer.com